Sulbactam–durlobactam: a β-lactam/β-lactamase inhibitor combination targeting <i>Acinetobacter baumannii</i>-Reference-Cited by-同舟云学术

Sulbactam–durlobactam: a β-lactam/β-lactamase inhibitor combination targeting Acinetobacter baumannii

Published:2024-03 Issue:7 Volume:19 Page:563-576
ISSN:1746-0913
Container-title:Future Microbiology
language:en
Short-container-title:Future Microbiology

Author:

McLeod Sarah M¹^ORCID,O'Donnell John P¹^ORCID,Narayanan Navaneeth²^ORCID,Mills John P³^ORCID,Kaye Keith S³^ORCID

Affiliation:

1. Innoviva Specialty Therapeutics, Inc., an affiliate of Entasis Therapeutics Inc., 35 Gatehouse Drive, Waltham, MA 02451, USA

2. Rutgers University Ernest Mario School of Pharmacy, Department of Pharmacy Practice & Administration, Piscataway, NJ 08901, USA

3. Division of Allergy, Immunology & Infectious Diseases, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.2217/fmb-2023-0248

Reference69 articles.

1. Centers for Disease Prevention and Control. Antibiotic Resistance Threats in the United States (2019). https://www.cdc.gov/drugresistance/biggest-threats.html (Accessed 14 January 2024).

2. European Centre for Disease Prevention and Control. Rapid Risk Assessment: Carbapenem-resistant Acinetobacter baumannii in Healthcare Settings (2016). https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessment-carbapenem-resistant-Acinetobacter-baumannii-healthcare (Accessed 14 January 2024).

3. Portrait of a killer: Uncovering resistance mechanisms and global spread of Acinetobacter baumannii

4. Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis

5. Mortality Attributable to Bloodstream Infections Caused by Different Carbapenem-Resistant Gram-Negative Bacilli: Results From a Nationwide Study in Italy (ALARICO Network)

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiresistente Bakterien – epidemiologische Trends und neue Behandlungsoptionen;DMW - Deutsche Medizinische Wochenschrift;2024-09

2. Optimizing Treatment for Carbapenem-Resistant Acinetobacter baumannii Complex Infections: A Review of Current Evidence;Infection & Chemotherapy;2024